about
TSH and Thyrotropic Agonists: Key Actors in Thyroid HomeostasisNew Frontier in Glycoprotein Hormones and Their Receptors Structure-FunctionRecent Advances in Autoimmune Thyroid DiseasesClinical Update in Aspects of the Management of Autoimmune Thyroid DiseasesStructural-Functional Features of the Thyrotropin Receptor: A Class A G-Protein-Coupled Receptor at WorkThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsNew small molecule agonists to the thyrotropin receptor.A small molecule antagonist inhibits thyrotropin receptor antibody-induced orbital fibroblast functions involved in the pathogenesis of Graves ophthalmopathy.TSH receptor antibodies have predictive value for breast cancer - retrospective analysis.An Enantiomer of an Oral Small-Molecule TSH Receptor Agonist Exhibits Improved Pharmacologic Properties.Novel insights on thyroid-stimulating hormone receptor signal transduction.A selective TSH receptor antagonist inhibits stimulation of thyroid function in female miceMolecular sampling of the allosteric binding pocket of the TSH receptor provides discriminative pharmacophores for antagonist and agonistsCurrent trends in antithyroid drug treatment of Graves' disease.Inhibiting thyrotropin/insulin-like growth factor 1 receptor crosstalk to treat Graves' ophthalmopathy: studies in orbital fibroblasts in vitro.The cell biology of the thyroid-disrupting mechanism of dichlorodiphenyltrichloroethane (DDT).Nonthionamide Drugs for the Treatment of Hyperthyroidism: From Present to Future.2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism
P2860
Q21296659-1C32B88A-1A4F-458A-A752-18B0A8EEA141Q26779481-B230D54B-7FA0-4BD5-921F-BF551479A10AQ28073651-CE7D754D-7DF9-4985-8CD0-307805645387Q28075859-394D6F6C-F662-402C-B111-06A59075E434Q30401802-45DFBFD9-E1BD-4ED8-9C7E-608F33175C04Q30486707-A47C82B9-EE52-4865-B644-5279DA86DF3FQ34918437-02F042A8-5F81-4FCF-9020-5E22C6F91769Q36817224-A5B6EA05-425F-419E-9C87-0CC2F7917DC0Q36871004-631814D2-6BE9-42BA-A893-D65143440101Q37127629-4CE7A666-06D8-4472-82EA-0E53CF6CC3E7Q37203610-5723A375-9C5C-426C-9142-4B5551A18E5EQ37405158-868368DD-DACC-4209-B9C5-C46D8C0626CCQ38077230-BC6D0075-09E5-4CA1-8CB9-08FA251B8107Q38822451-B69CB42A-21CB-4AE6-A065-A3E1EF71F147Q39093117-FF42F69E-3F57-4566-B06F-82D18ACFD15DQ39390101-E175BCD9-D747-4623-B593-7BF3BE7843C5Q55317644-9E01C842-DFE1-4BFB-B7EF-B5CDBECFB785Q57136607-F988BA88-567C-4852-9D08-003B9D9161C1
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Update in TSH receptor agonists and antagonists
@ast
Update in TSH receptor agonists and antagonists
@en
type
label
Update in TSH receptor agonists and antagonists
@ast
Update in TSH receptor agonists and antagonists
@en
prefLabel
Update in TSH receptor agonists and antagonists
@ast
Update in TSH receptor agonists and antagonists
@en
P2860
P356
P1476
Update in TSH receptor agonists and antagonists
@en
P2093
Marvin C Gershengorn
Susanne Neumann
P2860
P304
P356
10.1210/JC.2012-3080
P407
P577
2012-09-27T00:00:00Z